Definium Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026

Go back to Definium Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026
(NASDAQ: DFTX) Delayed: 36.67 +12.19 (49.80%)
Previous Close $24.48    52 Week High
Open $38.58    52 Week Low
Day High $39.16    P/E N/A 
Day Low $35.13    EPS
Volume 20,121,762